Iodoquinol

CAS No. 83-73-8

Iodoquinol( Iodoquinol, Diiodohydroxyquin, Diiodoquin, Diquinol, Sebaquin )

Catalog No. M16102 CAS No. 83-73-8

Diiodohydroxyquinoline is a topical therapeutic agent, with satisfactory antibacterial properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 28 In Stock

Biological Information

  • Product Name
    Iodoquinol
  • Note
    Research use only, not for human use.
  • Brief Description
    Diiodohydroxyquinoline is a topical therapeutic agent, with satisfactory antibacterial properties.
  • Description
    Diiodohydroxyquinoline is a topical therapeutic agent, with satisfactory antibacterial properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Iodoquinol, Diiodohydroxyquin, Diiodoquin, Diquinol, Sebaquin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    83-73-8
  • Formula Weight
    396.96
  • Molecular Formula
    C9H5I2NO
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    OC1=C2N=CC=CC2=C(I)C=C1I
  • Chemical Name
    5,7-diiodoquinolin-8-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fisher AK, et al. J Toxicol Clin Toxicol. 1993;31(1):113-20.
molnova catalog
related products
  • Deferasirox

    An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.

  • (3S)9,10-dihydroxy-7...

    (3S)9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-3,4-dihydro-1H-benzo[g]isochromene-3-carboxylic?acid?9-0-β-D-glucopyranoside

  • Trans-caffeic acid

    Trans-caffeic acid stearyl ester is posited to inhibit melanogenesis signaling while suppressing cAMP levels and, subsequently, MC1R, MITF, tyrosinase, TRP-2 and TRP-1 down-regulation, resulting in the suppression of tyrosinase activity, DOPA oxidase activity and melanin synthesis.